A carregar...
Predictors of low disease activity and clinical remission following belimumab treatment in systemic lupus erythematosus
OBJECTIVES: To identify predictors of low disease activity and clinical remission following belimumab treatment in SLE. METHODS: SLE patients who received belimumab 10 mg/kg (N = 563) in the BLISS-52 and BLISS-76 clinical trials were surveyed. The performance of baseline factors in predicting attain...
Na minha lista:
| Publicado no: | Rheumatology (Oxford) |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Oxford University Press
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6880848/ https://ncbi.nlm.nih.gov/pubmed/31157891 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/rheumatology/kez191 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|